AZTRAzitra Inc
0.1328USD+6.07%Mkt Cap: 2.15M $P/E: 6.643d ago
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap2.15M $
Enterprise Value1.73M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.96M $
Revenue/Share—
Last Price0.1328 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)6.64
P/E (Forward)-0.26
PEG—
EV/EBITDA-0.14
EV/Revenue—
P/S—
P/B1.10
EPS (TTM)0.02
EPS (Forward)-0.52
52W Range
0.10003% of range1.400
52W High1.400 USD
52W Low0.1000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-288.21%
ROA-218.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.22M $
CapEx (TTM)186.06K $
FCF Margin—
FCF Yield-336.78%
Net Debt-6.32M $
Net Debt/EBITDA0.52
Balance Sheet
Debt/Equity0.11
Current Ratio4.86
Quick Ratio4.49
Book Value/Sh0.1210 USD
Cash/Share0.1110 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split15:100
Split DateAug 21, 2025
Analyst Consensus
Rating—
Target (Mean)0.7750 USD
Upside (mean)+483.6%
Target Range0.5500 USD – 1.000 USD
$0.5500+483.6% to mean$1.000
# Analysts2
Ownership
Shares Out.60.60M
Float51.25M
Insiders7.59%
Institutions32.04%
Short Interest
Short Ratio0.1d
Short % Float1.46%
Short % Out.0.96%
Shares Short154.67K
Short (prev mo.)278.21K
Technical
SMA 500.1516 (-12.4%)
SMA 2000.2313 (-42.6%)
Beta-1.18
S&P 52W Chg19.18%
Avg Vol (30d)1.51M
Avg Vol (10d)1.12M
Technical Indicators
RSI (14)44.4
MACD-0.0051
MACD Signal-0.0065
MACD Hist.+0.0014
BB Upper0.1441 USD
BB Middle0.1336 USD
BB Lower0.1232 USD
BB Width15.61%
ATR (14)0.0115 USD
Vol Ratio (20d)1.46x